Literature DB >> 33496891

Radiologically isolated syndrome: from biological bases to practical management.

Andres G Barboza1, Edgar Carnero Contentti2, Maria Celeste Curbelo3, Mario Javier Halfon3,4, Juan Ignacio Rojas5, Berenice A Silva6, Vladimiro Sinay7, Santiago Tizio8, Maria Celica Ysrraelit9, Ricardo Alonso6,10.   

Abstract

BACKGROUND: Technological advances and greater availability of magnetic resonance imaging have prompted an increment on incidental and unexpected findings within the central nervous system. The concept of radiologically isolated syndrome characterizes a group of subjects with images suggestive of demyelinating disease in the absence of a clinical episode compatible with multiple sclerosis. Since the description of this entity, many questions have arisen; some have received responses but others remain unanswered. A panel of experts met with the objective of performing a critical review of the currently available evidence. Definition, prevalence, biological bases, published evidence, and implications on patient management were reviewed. Thirty to 50% of subjects with radiologically isolated syndrome will progress to multiple sclerosis in 5 years. Male sex, age < 37 years old, and spinal lesions increase the risk. These subjects should be evaluated by a multiple sclerosis specialist, carefully excluding alternative diagnosis. An initial evaluation should include a brain and complete spine magnetic resonance, visual evoked potentials, and identification of oligoclonal bands in cerebrospinal fluid. Disease-modifying therapies could be considered when oligoclonal bands or radiological progression is present.
CONCLUSION: At present time, radiologically isolated syndrome cannot be considered a part of the multiple sclerosis spectrum. However, a proportion of patients may evolve to multiple sclerosis, meaning it represents much more than just a radiological finding.

Entities:  

Keywords:  Biomarkers; Magnetic resonance imaging; Multiple sclerosis; Oligoclonal bands; Radiologically isolated syndrome

Mesh:

Substances:

Year:  2021        PMID: 33496891     DOI: 10.1007/s10072-021-05069-6

Source DB:  PubMed          Journal:  Neurol Sci        ISSN: 1590-1874            Impact factor:   3.307


  59 in total

1.  Isolated demyelinating syndromes: comparison of different MR imaging criteria to predict conversion to clinically definite multiple sclerosis.

Authors:  M Tintoré; A Rovira; M J Martínez; J Rio; P Díaz-Villoslada; L Brieva; C Borrás; E Grivé; J Capellades; X Montalban
Journal:  AJNR Am J Neuroradiol       Date:  2000-04       Impact factor: 3.825

2.  Imaging brain damage in first-degree relatives of sporadic and familial multiple sclerosis.

Authors:  Nicola De Stefano; Eleonora Cocco; Marina Lai; Marco Battaglini; Andrea Spissu; Piernicola Marchi; Gianluca Floris; Marzia Mortilla; Maria L Stromillo; Andrea Paolillo; Antonio Federico; Maria Giovanna Marrosu
Journal:  Ann Neurol       Date:  2006-04       Impact factor: 10.422

3.  Incidental MRI anomalies suggestive of multiple sclerosis: the radiologically isolated syndrome.

Authors:  D T Okuda; E M Mowry; A Beheshtian; E Waubant; S E Baranzini; D S Goodin; S L Hauser; D Pelletier
Journal:  Neurology       Date:  2008-12-10       Impact factor: 9.910

Review 4.  Diagnosis of multiple sclerosis: 2017 revisions of the McDonald criteria.

Authors:  Alan J Thompson; Brenda L Banwell; Frederik Barkhof; William M Carroll; Timothy Coetzee; Giancarlo Comi; Jorge Correale; Franz Fazekas; Massimo Filippi; Mark S Freedman; Kazuo Fujihara; Steven L Galetta; Hans Peter Hartung; Ludwig Kappos; Fred D Lublin; Ruth Ann Marrie; Aaron E Miller; David H Miller; Xavier Montalban; Ellen M Mowry; Per Soelberg Sorensen; Mar Tintoré; Anthony L Traboulsee; Maria Trojano; Bernard M J Uitdehaag; Sandra Vukusic; Emmanuelle Waubant; Brian G Weinshenker; Stephen C Reingold; Jeffrey A Cohen
Journal:  Lancet Neurol       Date:  2017-12-21       Impact factor: 44.182

5.  The contemporary spectrum of multiple sclerosis misdiagnosis: A multicenter study.

Authors:  Andrew J Solomon; Dennis N Bourdette; Anne H Cross; Angela Applebee; Philip M Skidd; Diantha B Howard; Rebecca I Spain; Michelle H Cameron; Edward Kim; Michele K Mass; Vijayshree Yadav; Ruth H Whitham; Erin E Longbrake; Robert T Naismith; Gregory F Wu; Becky J Parks; Dean M Wingerchuk; Brian L Rabin; Michel Toledano; W Oliver Tobin; Orhun H Kantarci; Jonathan L Carter; B Mark Keegan; Brian G Weinshenker
Journal:  Neurology       Date:  2016-08-31       Impact factor: 9.910

6.  Disease onset in familial and sporadic multiple sclerosis in Argentina.

Authors:  J I Rojas; L Patrucco; J MIguez; V Sinay; F Pagani Cassara; F Cáceres; N Fernandez Liguori; M L Saladino; N Deri; G Jaacks; M Parada Marcilla; M I Arrigoni; J Correale; M Fiol; M C Ysrraelit; A Carrá; M C Curbelo; A Martinez; J Steinberg; S Bestoso; J P Hryb; J L Di Pace; M B Perassolo; E Carnero Contentti; A Caride; P A Lopez; C Martinez; E Reich; E Cristiano
Journal:  Mult Scler Relat Disord       Date:  2016-01-19       Impact factor: 4.339

Review 7.  Migraine and structural changes in the brain: a systematic review and meta-analysis.

Authors:  Asma Bashir; Richard B Lipton; Sait Ashina; Messoud Ashina
Journal:  Neurology       Date:  2013-08-28       Impact factor: 9.910

8.  Incidence of Radiologically Isolated Syndrome: A Population-Based Study.

Authors:  Y Forslin; T Granberg; A Antwan Jumah; S Shams; P Aspelin; M Kristoffersen-Wiberg; J Martola; S Fredrikson
Journal:  AJNR Am J Neuroradiol       Date:  2016-02-04       Impact factor: 3.825

Review 9.  Diagnostic criteria for multiple sclerosis: 2005 revisions to the "McDonald Criteria".

Authors:  Chris H Polman; Stephen C Reingold; Gilles Edan; Massimo Filippi; Hans-Peter Hartung; Ludwig Kappos; Fred D Lublin; Luanne M Metz; Henry F McFarland; Paul W O'Connor; Magnhild Sandberg-Wollheim; Alan J Thompson; Brian G Weinshenker; Jerry S Wolinsky
Journal:  Ann Neurol       Date:  2005-12       Impact factor: 10.422

10.  Diagnostic criteria for multiple sclerosis: 2010 revisions to the McDonald criteria.

Authors:  Chris H Polman; Stephen C Reingold; Brenda Banwell; Michel Clanet; Jeffrey A Cohen; Massimo Filippi; Kazuo Fujihara; Eva Havrdova; Michael Hutchinson; Ludwig Kappos; Fred D Lublin; Xavier Montalban; Paul O'Connor; Magnhild Sandberg-Wollheim; Alan J Thompson; Emmanuelle Waubant; Brian Weinshenker; Jerry S Wolinsky
Journal:  Ann Neurol       Date:  2011-02       Impact factor: 10.422

View more
  1 in total

Review 1.  Secondary Prevention in Radiologically Isolated Syndromes and Prodromal Stages of Multiple Sclerosis.

Authors:  Maria Pia Amato; Nicola De Stefano; Matilde Inglese; Emanuele Morena; Giovanni Ristori; Marco Salvetti; Maria Trojano
Journal:  Front Neurol       Date:  2022-03-14       Impact factor: 4.003

  1 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.